Hepatitis B Virus X Protein Amplifies TGF-β Promotion on HCC Motility Through Down-regulating PPM1a

Overview

Journal Oncotarget

Specialty Oncology

Date 2016 Apr 29

PMID 27121309

Citations 22

Authors

Yuan Liu

Yong Xu

Hongxin Ma

Bo Wang

Leiqi Xu

Hualin Zhang

Xiaojia Song

Lifen Gao

Xiaohong Liang

Chunhong Ma

Affiliations

Soon will be listed here.

Abstract

Over-activation of transforming growth factor-β (TGF-β) signaling pathway promotes cell migration and invasion in hepatocellular carcinoma (HCC). The Hepatitis B virus X protein (HBx) is involved in the enhancement of TGF-β signaling pathway in HCC while the mechanism remains unclear. Protein phosphatase magnesium dependent 1A (PPM1a) functions as a phosphatase essential for terminating the TGF-β signaling pathway by dephosphorylating p-Smad2/3. In this study, we found that HBx dose-dependently downregulated PPM1a protein level in the presence of TGF-β, while having no effect on its mRNA level. Further study showed that HBx increased the ubiquitination of PPM1a and accelerated its proteasomal degradation. Restoration of PPM1a almost completely abrogated HBx mediated promotion on HCC migration and invasion. This involvement of PPM1a in HBx-related HCC was further confirmed with immunohistochemical analysis in HCC tissue. Compared with paired pericarcinous tissue, HCC tissue showed decreased PPM1a level. Besides, PPM1a level is negatively correlated with HBx expression. Taken together, our present study suggests that HBx-induced degradation of PPM1a is a novel mechanism for over-activation of TGF-β pathway in HCC development, which might provide potential candidates for clinical diagnosis and treatment.

Citing Articles

Insight into the mechanisms regulating liver cancer stem cells by hepatitis B virus X protein.

Li X, Kong D, Hu W, Zheng K, You H, Tang R Infect Agent Cancer. 2024; 19(1):56.

PMID: 39529119 PMC: 11555838. DOI: 10.1186/s13027-024-00618-y.

Magnesium Ion: A New Switch in Tumor Treatment.

Huang L, Lin R, Chen J, Qi Y, Lin L Biomedicines. 2024; 12(8).

PMID: 39200180 PMC: 11351748. DOI: 10.3390/biomedicines12081717.

Hepatitis B virus X protein and TGF-β: partners in the carcinogenic journey of hepatocellular carcinoma.

Yan W, Rao D, Fan F, Liang H, Zhang Z, Dong H Front Oncol. 2024; 14:1407434.

PMID: 38962270 PMC: 11220127. DOI: 10.3389/fonc.2024.1407434.

System Biology Investigation Revealed Lipopolysaccharide and Alcohol-Induced Hepatocellular Carcinoma Resembled Hepatitis B Virus Immunobiology and Pathogenesis.

Patil V, Harish D, Sampat G, Roy S, Jalalpure S, Khanal P Int J Mol Sci. 2023; 24(13).

PMID: 37446321 PMC: 10342420. DOI: 10.3390/ijms241311146.

Magnesium and Liver Metabolism Through the Lifespan.

Bravo M, Simon J, Gonzalez-Recio I, Martinez-Cruz L, Goikoetxea-Usandizaga N, Martinez-Chantar M Adv Nutr. 2023; 14(4):739-751.

PMID: 37207838 PMC: 10334155. DOI: 10.1016/j.advnut.2023.05.009.

References

Lin X, Duan X, Liang Y, Su Y, Wrighton K, Long J . PPM1A functions as a Smad phosphatase to terminate TGFbeta signaling. Cell. 2006; 125(5):915-28. PMC: 6309366. DOI: 10.1016/j.cell.2006.03.044. View

Zhang S, Sun W, Wu J, Wei W . TGF-β signaling pathway as a pharmacological target in liver diseases. Pharmacol Res. 2014; 85:15-22. DOI: 10.1016/j.phrs.2014.05.005. View

Dvashi Z, Sar Shalom H, Shohat M, Ben-Meir D, Ferber S, Satchi-Fainaro R . Protein phosphatase magnesium dependent 1A governs the wound healing-inflammation-angiogenesis cross talk on injury. Am J Pathol. 2014; 184(11):2936-50. DOI: 10.1016/j.ajpath.2014.07.022. View

Bedossa P, Peltier E, Terris B, Franco D, Poynard T . Transforming growth factor-beta 1 (TGF-beta 1) and TGF-beta 1 receptors in normal, cirrhotic, and neoplastic human livers. Hepatology. 1995; 21(3):760-6. View

Wang J, Tucker-Kellogg L, Ng I, Jia R, Thiagarajan P, White J . The self-limiting dynamics of TGF-β signaling in silico and in vitro, with negative feedback through PPM1A upregulation. PLoS Comput Biol. 2014; 10(6):e1003573. PMC: 4105941. DOI: 10.1371/journal.pcbi.1003573. View

Pickart C . Back to the future with ubiquitin. Cell. 2004; 116(2):181-90. DOI: 10.1016/s0092-8674(03)01074-2. View

Murata M, Matsuzaki K, Yoshida K, Sekimoto G, Tahashi Y, Mori S . Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B. Hepatology. 2009; 49(4):1203-17. DOI: 10.1002/hep.22765. View

Neuzillet C, de Gramont A, Tijeras-Raballand A, de Mestier L, Cros J, Faivre S . Perspectives of TGF-β inhibition in pancreatic and hepatocellular carcinomas. Oncotarget. 2014; 5(1):78-94. PMC: 3960190. DOI: 10.18632/oncotarget.1569. View

Lammers T, Lavi S . Role of type 2C protein phosphatases in growth regulation and in cellular stress signaling. Crit Rev Biochem Mol Biol. 2007; 42(6):437-61. DOI: 10.1080/10409230701693342. View

10.

Feng X, Derynck R . Specificity and versatility in tgf-beta signaling through Smads. Annu Rev Cell Dev Biol. 2005; 21:659-93. DOI: 10.1146/annurev.cellbio.21.022404.142018. View

11.

Achyut B, Yang L . Transforming growth factor-β in the gastrointestinal and hepatic tumor microenvironment. Gastroenterology. 2011; 141(4):1167-78. PMC: 6644047. DOI: 10.1053/j.gastro.2011.07.048. View

12.

Geng J, Fan J, Ouyang Q, Zhang X, Zhang X, Yu J . Loss of PPM1A expression enhances invasion and the epithelial-to-mesenchymal transition in bladder cancer by activating the TGF-β/Smad signaling pathway. Oncotarget. 2014; 5(14):5700-11. PMC: 4170610. DOI: 10.18632/oncotarget.2144. View

13.

Ito N, Kawata S, Tamura S, Takaishi K, Shirai Y, Kiso S . Elevated levels of transforming growth factor beta messenger RNA and its polypeptide in human hepatocellular carcinoma. Cancer Res. 1991; 51(15):4080-3. View

14.

Klumpp S, Thissen M, Krieglstein J . Protein phosphatases types 2Calpha and 2Cbeta in apoptosis. Biochem Soc Trans. 2006; 34(Pt 6):1370-5. DOI: 10.1042/BST0341370. View

15.

Lee D, Park S, Yi Y, Choi S, Lee C, Parks W . The hepatitis B virus encoded oncoprotein pX amplifies TGF-beta family signaling through direct interaction with Smad4: potential mechanism of hepatitis B virus-induced liver fibrosis. Genes Dev. 2001; 15(4):455-66. PMC: 312630. DOI: 10.1101/gad.856201. View

16.

Wu S, Wang B, Yang Y, Feng X, Zhao X, Yang D . Expression of PTEN, PPM1A and P-Smad2 in hepatocellular carcinomas and adjacent liver tissues. World J Gastroenterol. 2007; 13(34):4554-9. PMC: 4611826. DOI: 10.3748/wjg.v13.i34.4554. View

17.

Ng S, Lee C . Hepatitis B virus X gene and hepatocarcinogenesis. J Gastroenterol. 2011; 46(8):974-90. DOI: 10.1007/s00535-011-0415-9. View

18.

Torre L, Bray F, Siegel R, Ferlay J, Lortet-Tieulent J, Jemal A . Global cancer statistics, 2012. CA Cancer J Clin. 2015; 65(2):87-108. DOI: 10.3322/caac.21262. View

19.

Perz J, Armstrong G, Farrington L, Hutin Y, Bell B . The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006; 45(4):529-38. DOI: 10.1016/j.jhep.2006.05.013. View

20.

Giannelli G, Mazzocca A, Fransvea E, Lahn M, Antonaci S . Inhibiting TGF-β signaling in hepatocellular carcinoma. Biochim Biophys Acta. 2010; 1815(2):214-23. DOI: 10.1016/j.bbcan.2010.11.004. View